ArticleOPEN ACCESS

Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming

Journal of Internal Medicine
DOI: 10.1111/joim.13366
20Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Hansen, C. B., Jarlhelt, I., Hasselbalch, R. B., Hamm, S. R., Fogh, K., Pries-Heje, M. M., … Garred, P. (2021, December 1). Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming. Journal of Internal Medicine. John Wiley and Sons Inc. https://doi.org/10.1111/joim.13366

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free